MET and FASN as Prognostic Biomarkers of Triple Negative Breast Cancer: A Systematic Evidence Landscape of Clinical Study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MET and FASN as Prognostic Biomarkers of Triple Negative Breast Cancer: A Systematic Evidence Landscape of Clinical Study
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-05-27
DOI
10.3389/fonc.2021.604801
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Atezolizumab in the treatment of metastatic triple-negative breast cancer
- (2020) José Pérez-García et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- c-Src Recruitment is Involved in c-MET-Mediated Malignant Behaviour of NT2D1 Non-Seminoma Cells
- (2019) Erica Leonetti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification of aberrantly methylated differentially expressed genes in prostate carcinoma using integrated bioinformatics
- (2019) Kai Wu et al. Cancer Cell International
- Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway
- (2019) Ligong Chang et al. Lipids in Health and Disease
- Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells
- (2019) Patricia Gaule et al. Cancers
- FEN1 mediates miR-200a methylation and promotes breast cancer cell growth via MET and EGFR signaling
- (2019) Xue Zeng et al. FASEB JOURNAL
- c-MET as a biomarker in patients with surgically resected non-small cell lung cancer
- (2019) Georgios Tsakonas et al. LUNG CANCER
- EGFL9 promotes breast cancer metastasis by inducing cMET activation and metabolic reprogramming
- (2019) Fanyan Meng et al. Nature Communications
- The Role of c-Met as a Biomarker and Player in Innate and Acquired Resistance in Non-Small-Cell Lung Cancer: Two New Mutations Warrant Further Studies
- (2019) Nele Van Der Steen et al. MOLECULES
- Dual targeting c-met and VEGFR2 in osteoblasts suppresses growth and osteolysis of prostate cancer bone metastasis
- (2018) Changki Lee et al. CANCER LETTERS
- miR-146a targets c-met and abolishes colorectal cancer liver metastasis
- (2018) Anne-Marie Bleau et al. CANCER LETTERS
- MicroRNA-454-3p inhibits cervical cancer cell invasion and migration by targeting c-Met
- (2018) Yan Guo et al. Experimental and Therapeutic Medicine
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines
- (2018) Aleksandra Simiczyjew et al. Cancers
- Fatty acid synthase (FASN) as a therapeutic target in breast cancer
- (2017) Javier A. Menendez et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents
- (2017) Nehad Ayoub et al. OncoTargets and Therapy
- Fatty acid synthase regulates estrogen receptor-α signaling in breast cancer cells
- (2017) J A Menendez et al. Oncogenesis
- Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple-Negative Breast Cancer
- (2016) A. Giro-Perafita et al. CLINICAL CANCER RESEARCH
- c-Met and ERβ expression differences in basal-like and non-basal-like triple-negative breast cancer
- (2016) Xinyu Ren et al. TUMOR BIOLOGY
- Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6
- (2015) YONG WEON YI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET
- (2015) Chao Han et al. TUMOR BIOLOGY
- MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1
- (2015) Richa Singh et al. Scientific Reports
- Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase
- (2013) XING HUA LONG et al. Experimental and Therapeutic Medicine
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Fatty acid synthase as a potential therapeutic target in cancer
- (2010) Richard Flavin et al. Future Oncology
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- The Met tyrosine kinase receptor in development and cancer
- (2008) Alessandra Gentile et al. CANCER AND METASTASIS REVIEWS
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now